CF PHARMTECH (02652) spent HK$344,000 to repurchase 16,500 shares on May 13th.
Changfeng Pharmaceutical (02652) announced that it repurchased 16,500 shares for 344,000 Hong Kong dollars on May 13, 2026.
CF PHARMTECH (02652) announced that it will spend HK$344,000 to repurchase 16,500 shares on May 13, 2026.
Related Articles
On May 13, BLACK SESAME (02533) repurchased 1.2838 million shares for 22.645 million Hong Kong dollars.
FSM HOLDINGS(01721): The restriction order mainly involves Mr. Li's personal assets, not any assets, business, or operations of the Group.
CALB (03931) suggests appointing PricewaterhouseCoopers Hong Kong as the company's H-share audit firm for the year 2026.
On May 13, BLACK SESAME (02533) repurchased 1.2838 million shares for 22.645 million Hong Kong dollars.
FSM HOLDINGS(01721): The restriction order mainly involves Mr. Li's personal assets, not any assets, business, or operations of the Group.
CALB (03931) suggests appointing PricewaterhouseCoopers Hong Kong as the company's H-share audit firm for the year 2026.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
